Neuraxial Anesthesia and Restless Leg Syndromes in Cesarean

NCT ID: NCT00872248

Last Updated: 2011-07-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

350 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-02-28

Study Completion Date

2011-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The restless leg syndromes is a common sensorimotor disorder of unknown cause affecting approximately 10% of the population. Different literature had different views on the association between neuraxial anesthesia and the occurrence of restless leg syndrome. Some reported that spinal anesthesia induced postoperative restless leg syndrome, but other studies showed that spinal and general anesthesia all two did not cause restless leg syndrome. A potential difference amongst these studies is that a big difference exists in surgical types. The investigators proposed that different types of surgery performed undergoing various anesthesia, and that there is a big difference in original pathophysiological condition. Therefore, the investigators hypothesized that pregnant women who have special physical states would have had an association between neuraxial anesthesia and restless leg syndrome in such patients who received selective cesarean section undergoing spinal or epidural anesthesia.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cesarean Section Restless Leg Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Parturients received spinal anesthesia

Group Type EXPERIMENTAL

Spinal anesthesia

Intervention Type PROCEDURE

Procedures of spinal anesthesia with bupivacaine 0.5%, 10-15mg

2

Parturients received epidural anesthesia

Group Type ACTIVE_COMPARATOR

Epidural anesthesia

Intervention Type PROCEDURE

Procedures of epidural anesthesia with ropivacaine 0.75%, 75-120mg

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Spinal anesthesia

Procedures of spinal anesthesia with bupivacaine 0.5%, 10-15mg

Intervention Type PROCEDURE

Epidural anesthesia

Procedures of epidural anesthesia with ropivacaine 0.75%, 75-120mg

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Intrathecal anesthesia Extradural anesthesia

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy pregnancy
* Selective cesarean
* Gestational age \>= 37 weeks
* Chinese

Exclusion Criteria

* Allergic to local anesthetics
* Allergic to opioids
* History of psychosis
* Cognition malfunction
* Any organic diseases
* Original lower extremity dyskinesia and paraesthesia
* Chronic pain
* Difficult in sleep
* Drug and alcohol abuse
Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Nanjing Medical University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Nanjing Medical University

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

XiaoFeng Shen, MD

Role: STUDY_DIRECTOR

Nanjing Medical University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Nanjing Maternal and Child Health Care Hospital

Nanjing, Jiangsu, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NJFY09102M112

Identifier Type: -

Identifier Source: secondary_id

NMU-200903-MZ005

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Dexmedetomidine for Cesarean Section
NCT02715154 COMPLETED PHASE1